Medifast, Inc.
MED
$13.49
$0.302.27%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.60% | -110.33% | -97.90% | -93.89% | -77.93% |
| Total Depreciation and Amortization | 4.67% | -4.99% | -3.05% | -71.00% | 7.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.79% | 65.90% | 30.71% | 267.79% | 62.44% |
| Change in Net Operating Assets | -74.62% | -106.17% | -148.06% | -131.74% | -117.87% |
| Cash from Operations | -93.17% | -77.33% | -83.42% | -78.85% | -71.63% |
| Capital Expenditure | -2.69% | -14.91% | -14.98% | 58.12% | 56.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.05% | 66.37% | 65.06% | 73.86% | -- |
| Cash from Investing | 84.14% | 58.19% | 56.56% | 69.99% | -325.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -80.85% | 13.33% | 13.33% |
| Repurchase of Common Stock | 60.86% | 58.68% | 87.99% | 93.67% | 92.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 99.47% | 99.64% | 99.02% | 74.38% | 49.68% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.49% | 98.94% | 98.10% | 77.48% | 66.80% |
| Foreign Exchange rate Adjustments | 103.13% | 148.48% | 165.28% | 36.97% | 11.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.95% | 78.10% | -152.04% | -94.06% | -145.62% |